Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CHC Healthcare GroupTPE:4164 +0.19%76 Return-on-Tangible-Equity is 1.53% as of Mar. 2026, which is 77% below its 10-year median of 6.63. GuruFocus rates TPE:4164 with a GF Score™ of 76/100 and a GF Value™ of NT$52.32 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 111 Medical Distribution companies, CHC Healthcare Group ranks worse than 73.87% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. CHC Healthcare Group's annualized net income for the quarter that ended in Mar. 2026 was NT$105 Mil. CHC Healthcare Group's average shareholder tangible equity for the quarter that ended in Mar. 2026 was NT$6,846 Mil. Therefore, CHC Healthcare Group's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 1.53%.
The historical rank and industry rank for CHC Healthcare Group's Return-on-Tangible-Equity or its related term are showing as below:
TPE:4164'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -1.81 Med: 6.63 Max: 8.05
Current: 3.09
During the past 13 years, CHC Healthcare Group's highest Return-on-Tangible-Equity was 8.05%. The lowest was -1.81%. And the median was 6.63%.
TPE:4164's Return-on-Tangible-Equity is ranked worse than 73.87% of 111
companies
in the Medical Distribution industry
Industry Median: 8.78
vs TPE:4164: 3.09
CHC Healthcare Group (TPE:4164) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
CHC Healthcare Group Return-on-Tangible-Equity Related Terms
CHC Healthcare Group Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for CHC Healthcare Group's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHC Healthcare Group Return-on-Tangible-Equity Chart
TPE:4164 vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, CHC Healthcare Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CHC Healthcare Group Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where CHC Healthcare Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 1.53% mean?
CHC Healthcare Group (TPE:4164) has a Return-on-Tangible-Equity of 1.53% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on CHC Healthcare Group and its competitors. This is 77% below median its historical median of 6.63. According to the industry distribution chart, CHC Healthcare Group ranks #82 out of 111 companies in the Medical Distribution industry, placing it in the top 73.9%.
Is CHC Healthcare Group's Return-on-Tangible-Equity too high?
CHC Healthcare Group's current Return-on-Tangible-Equity of 1.53% is 77% below median its 10-year median of 6.63. The Medical Distribution industry median Return-on-Tangible-Equity is 8.78. CHC Healthcare Group's value of 1.53% is 82.6% below this industry median. Based on the distribution chart, CHC Healthcare Group ranks #82 out of 111 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, CHC Healthcare Group has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CHC Healthcare Group's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, CHC Healthcare Group ranks #82 out of 111 companies for Return-on-Tangible-Equity. This places CHC Healthcare Group in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.78. CHC Healthcare Group's value of 1.53% is 82.6% below this benchmark. While the company's 10-year median is 6.63 vs. the industry median of 8.78, CHC Healthcare Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.78, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CHC Healthcare Group's current Return-on-Tangible-Equity of 1.53% is 82.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on CHC Healthcare Group and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CHC Healthcare Group's current Return-on-Tangible-Equity is 1.53%, which is 77% below median its own 10-year median of 6.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHC Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, CHC Healthcare Group (TPE:4164) is currently considered Possible Value Trap. The stock's GF Value™ is NT$52.32, compared to a current price of NT$26.05 — trading 50.2% below its estimated fair value. The current Return-on-Tangible-Equity is 1.53%, which is 77% below median its 10-year median of 6.63 and 82.6% below the Medical Distribution industry median of 8.78. CHC Healthcare Group's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For CHC Healthcare Group (TPE:4164), the current Return-on-Tangible-Equity is 1.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CHC Healthcare Group (TPE:4164) Overvalued in 2026?
Based on GuruFocus' analysis, CHC Healthcare Group stock appears to be undervalued.
The current stock price of NT$26.05 is trading 50.2% below its estimated GF Value™ of NT$52.32.
GuruFocus considers CHC Healthcare Group to be Possible Value Trap.
Key valuation signals for TPE:4164:
Return-on-Tangible-Equity: 1.53% (77% below median its 10-year median of 6.63)
GF Value™: NT$52.32 vs. price of NT$26.05 (50.2% below fair value)
Industry Position: 82.6% below the Medical Distribution median (#82 of 111)
No single metric tells the full story. See the TPE:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and health food, as well as the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment used in radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, the sale of medical instruments, repairs, maintenance, and other services.
76GF Score
Get the complete analysis for TPE:4164
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4164 has been successfully added to your 
